BSX
Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 40.80$. Average daily volumn in 3 months 6.65M. Market cap 56.19B
Stock symbol : BSX. Exchange : NYSE. Currency : USD Lastest price : 39.25$. Total volume : 4.09M. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Boston Scientific Corporation (BSX)
Last Price
39.25$Change
0.12Volume
4.09M
| Previous Close | 39.13 |
| Open | 38.92 |
| Day Range | 38.54-39.49 |
| Bid | 39.31 x 900 |
| Ask | 39.32 x 800 |
| Volume | 4.09M |
| Average Volume | 6.65M |
| Market Cap | 56.19B |
| Beta | 0.85 |
| 52 Week Range | 34.98-47.50 |
| Trailing P/E | 68.86 |
| Foward P/E | 19.92 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Market Cap:
56.19BRevenue:
11.89BTotal Assets:
32.23BTotal Cash:
1.93B
News about "Boston Scientific Corporation"
Artisan Partners Believes that Boston Scientific Corporation (BSX) is Well-Positioned in the Market
Source from : Insider Monkey - 2 days ago
Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter investor letter. A copy of the same can be downloaded here.See details»
Is It Time To Consider Buying Boston Scientific Corporation (NYSE:BSX)?
Source from : YAHOO!Finance - 2 days ago
Boston Scientific Corporation ( NYSE:BSX ) received a lot of attention from a substantial price movement on the ...See details»
Boston Scientific (BSX) Benefits From New Buyouts, FX Woes Stay
Source from : YAHOO!Finance - 2 days ago
Boston Scientific's (BSX) organic growth performance is strong across all regions where most of its businesses are growing at the same pace or faster than their competitors in the respective markets.See details»
Veriti Management LLC Grows Holdings in Boston Scientific Co. (NYSE:BSX)
Source from : Defense World - 2 days ago
Veriti Management LLC increased its stake in Boston Scientific Co. (NYSE:BSX – Get Rating) by 1.9% in the second quarter, according to the company in its most recent disclosure with the Securities and ...See details»
Here's Why You Should Retain Boston Scientific (BSX) For Now
Source from : Yahoo - 9 days ago
Boston Scientific Corporation BSX is gaining substantial contributions from its notable buyouts. The company posted better-than-expected results for the second quarter of 2022. The robust ...See details»
Boston Scientific: Making the Most of Its First 25 Years
Source from : MD&M East - 4 days ago
The first magazine covering device manufacturing, MD&DI, has just begun publication. In this uncertain, diversified, decentralized environment, Boston Scientific Corp. is founded. The new company, a ...See details»
Allworth Financial LP Increases Stock Holdings in Boston Scientific Co. (NYSE:BSX)
Source from : Defense World - 2 days ago
Allworth Financial LP increased its holdings in Boston Scientific Co. (NYSE:BSX – Get Rating) by 14.4% in the second quarter, according to its most recent Form 13F filing with the Securities & ...See details»
Truveta Announces Collaboration with Boston Scientific
Source from : Endovascular Today - 2 days ago
Truveta announced a strategic collaborative agreement with Boston Scientific Corporation whereby Boston Scientific researcher ...See details»
Cramer's lightning round: I like Boston Scientific over Medtronic
Source from : CNBC - 6 days ago
Loading chart... Boston Scientific Corp: "I've worked and seen doctors with their stuff. It is breakthrough. BSX is a much better company than Medtronic." Loading chart... Dow Inc: "Don't buy it back.See details»
Boston Scientific Gets FDA Approval For Expanded Labeling Of WATCHMAN FLX LAAC Device
Source from : Finanznachrichten - 3 days ago
WASHINGTON (dpa-AFX) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday that it has received U.S. Food and Drug Administration approval for expanded labeling of WATCHMAN ...See details»
Boston Scientific Snags Expanded Labeling FDA Nod for LAAC Device
Source from : MD&M East - 5 days ago
Boston Scientific Corporation today announced it has received FDA approval to expand the instructions for use in labeling the current-generation WATCHMAN FLX Left Atrial Appendage Closure (LAAC) ...See details»
Police looking to identify person connected to South Boston sex assault
Source from : CBS News - 7 hours ago
BOSTON – Police are looking to identify a man connected to a sex assault in South Boston. Boston Police released surveillance images of the person. They say the assault happened Friday in the area of ...See details»
Urinary Incontinence Treatment Devices Market Business overview 2022, and Forecast to 2029 | Boston Scientific Corporation, Promedon Group
Source from : MarketWatch - 8 days ago
The Urinary Incontinence Treatment Devices Market is expected to grow at a CAGR of 3.6% during the forecast period 2022-2028. Top Companies: Boston Scientific Corporation, Promedon Group, Medtronic ...See details»
Why Jim Cramer Says He Likes This Stock Over Medtronic
Source from : Benzinga.com - 6 days ago
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Boston Scientific Corporation BSX is a much better company than Medtronic plc MDT. When asked about Dow Inc. DOW, Cramer said, "Don’t buy ...See details»